ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (19)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Póvoa, P.
Right arrow Articles by Sabino, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Póvoa, P.
Right arrow Articles by Sabino, H.
Eur Respir J 2005; 25:804-812
Copyright ©ERS Journals Ltd 2005

C-reactive protein as a marker of ventilator-associated pneumonia resolution: a pilot study

P. Póvoa, L. Coelho, E. Almeida, A. Fernandes, R. Mealha, P. Moreira and H. Sabino

Intensive Care Unit, Garcia de Orta Hospital, Almada, Portugal

CORRESPONDENCE: P. Póvoa, Unidade de Cuidados Intensivos, Hospital Garcia de Orta, Av. Prof. Torrado da Silva, 2800-525 Almada, Portugal. Fax: 351 212957004. E-mail: povoap@netcabo.pt

Keywords: C-reactive protein, intensive care unit, outcome, temperature, ventilator-associated pneumonia, white cell count

Received: June 15, 2004
Accepted December 13, 2004

The aim of this study was to evaluate C-reactive protein (CRP) levels, body temperature and white cell count (WCC) after prescription of antibiotics in order to describe the clinical resolution of ventilator-associated pneumonia (VAP).

A cohort of 47 VAP patients with microbiological confirmation of disease was assessed. CRP levels, body temperature and WCC were monitored daily.

On day 4 of the antibiotic therapy, the CRP level of survivors was 0.62 times the initial value, whereas, in nonsurvivors, it was 0.98. Body temperature and WCC remained almost unchanged. By day 4, a CRP of >0.6 times the initial level was a marker of poor outcome (sensitivity 0.92; specificity 0.59). Patients were divided according to their CRP patterns of response to antibiotics: fast response, slow response, nonresponse, and biphasic response. All patients with fast and slow response patterns survived, whereas those showing nonresponse and a biphasic response pattern exhibited a mortality of 78 and 75%, respectively. The adequacy of the initial antibiotic therapy had a marked influence on the rate of CRP decrease, as well as on mortality.

In conclusion, daily C-reactive protein measurements after antibiotic prescription were useful in the identification, as early as day 4, of ventilator-associated pneumonia patients with poor outcome. The identification of the pattern of C-reactive protein response to antibiotics was useful in the recognition of individual clinical course, improving or worsening, as well as of the rate of improvement.




This article has been cited by other articles:


Home page
Ann Clin BiochemHome page
C. F M Linssen, O. Bekers, M. Drent, and J. A Jacobs
C-reactive protein and procalcitonin concentrations in bronchoalveolar lavage fluid as a predictor of ventilator-associated pneumonia
Ann Clin Biochem, May 1, 2008; 45(3): 293 - 298.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
R Menendez, M Cavalcanti, S Reyes, J Mensa, R Martinez, M A Marcos, X Filella, M Niederman, and A Torres
Markers of treatment failure in hospitalised community acquired pneumonia
Thorax, May 1, 2008; 63(5): 447 - 452.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. Poelaert, P. Depuydt, A. De Wolf, S. Van de Velde, I. Herck, and S. Blot
Polyurethane cuffed endotracheal tubes to prevent early postoperative pneumonia after cardiac surgery: A pilot study.
J. Thorac. Cardiovasc. Surg., April 1, 2008; 135(4): 771 - 776.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
P. Ramirez, M. A. Garcia, M. Ferrer, J. Aznar, M. Valencia, J. M. Sahuquillo, R. Menendez, M. A. Asenjo, and A. Torres
Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia
Eur. Respir. J., February 1, 2008; 31(2): 356 - 362.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
R. Menendez and A. Torres
Treatment Failure in Community-Acquired Pneumonia
Chest, October 1, 2007; 132(4): 1348 - 1355.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
R. Isozumi, Y. Ito, T. Ishida, M. Osawa, T. Hirai, I. Ito, K. Maniwa, M. Hayashi, H. Kagioka, M. Hirabayashi, et al.
Genotypes and Related Factors Reflecting Macrolide Resistance in Pneumococcal Pneumonia Infections in Japan
J. Clin. Microbiol., May 1, 2007; 45(5): 1440 - 1446.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
E. B. Milbrandt, A. Ishizaka, and D. C. Angus
Update in critical care 2005.
Am. J. Respir. Crit. Care Med., April 15, 2006; 173(8): 833 - 841.
[Full Text] [PDF]


Home page
Eur Respir JHome page
S. Teramoto, T. Ishii, H. Yamamoto, Y. Yamaguchi, and Y. Ouchi
Nasogastric tube feeding is a cause of aspiration pneumonia in ventilated patients
Eur. Respir. J., February 1, 2006; 27(2): 436 - 437.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the European Respiratory Society.